PPIDT00373
Drug Information
| Name | Mifamurtide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB13615 |
| Type | small molecule |
| Indication | Indicated in children, adolescents and young adults for the treatment of high-grade, resectable, non-metastatic osteosarcoma after macroscopically complete surgical resection, typically in combination with post-operative multi-agent chemotherapy [L1203]. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Powder | Intravenous |
4 mg
|
| Powder | Intravenous; Parenteral |
4 MG
|
| Injection | Parenteral |
4 mg
|
| Powder | Intravenous |
400000 mg
|